scispace - formally typeset
L

Louis Girard

Researcher at University of Calgary

Publications -  23
Citations -  766

Louis Girard is an academic researcher from University of Calgary. The author has contributed to research in topics: Medicine & Vasculitis. The author has an hindex of 10, co-authored 18 publications receiving 454 citations. Previous affiliations of Louis Girard include Cardiovascular Institute of the South.

Papers
More filters
Journal ArticleDOI

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

TL;DR: Among patients with severe ANCA-associated vasculitis, the use of plasma exchange did not reduce the incidence of death or ESKD, and a reduced-dose regimen of glucocorticoids was noninferior to a standard- dose regimen with respect to death orESKD.
Journal ArticleDOI

MIC Versus MBEC to Determine the Antibiotic Sensitivity of Staphylococcus aureus in Peritoneal Dialysis Peritonitis

TL;DR: In PD peritonitis that is long standing, recurrent, or not responsive to therapy, MBEC testing should be considered as a biofilm may be present, and Gentamicin should be strongly considered over other agents for empiric gram-negative coverage.
Journal ArticleDOI

Simulation Training Improves Diagnostic Performance on a Real Patient With Similar Clinical Findings

TL;DR: Students trained on mitral regurgitation were more likely to identify and diagnose these findings on a real patient with mitral Regurgitation than those who had trained on aortic stenosis or a scenario with no cardiac murmur.
Journal ArticleDOI

Immunoglobulin A–dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection

TL;DR: Renal function improved after therapy in 5 nondiabetic patients, but full recovery was not seen during the follow-up, and an association with community-associated methicillin-resistant S aureus was recorded for the first time.
Journal ArticleDOI

Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody–associated glomerulonephritis☆☆☆

TL;DR: Patients with crescentic class biopsies showed significantly more improvement in eGFR at 1 year compared with the mixed and sclerotic classes and it is suggested that it may be generalizable.